FR2298336B1 - - Google Patents

Info

Publication number
FR2298336B1
FR2298336B1 FR7602011A FR7602011A FR2298336B1 FR 2298336 B1 FR2298336 B1 FR 2298336B1 FR 7602011 A FR7602011 A FR 7602011A FR 7602011 A FR7602011 A FR 7602011A FR 2298336 B1 FR2298336 B1 FR 2298336B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7602011A
Other languages
French (fr)
Other versions
FR2298336A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of FR2298336A1 publication Critical patent/FR2298336A1/fr
Application granted granted Critical
Publication of FR2298336B1 publication Critical patent/FR2298336B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/14Angiotensins: Related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR7602011A 1975-01-27 1976-01-26 Derives d'octapeptides comportant un fragment c Granted FR2298336A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/544,128 US3975365A (en) 1975-01-27 1975-01-27 Inhibitory octapeptides angiotensin II

Publications (2)

Publication Number Publication Date
FR2298336A1 FR2298336A1 (fr) 1976-08-20
FR2298336B1 true FR2298336B1 (US20110009641A1-20110113-C00256.png) 1979-10-05

Family

ID=24170866

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7602011A Granted FR2298336A1 (fr) 1975-01-27 1976-01-26 Derives d'octapeptides comportant un fragment c

Country Status (15)

Country Link
US (1) US3975365A (US20110009641A1-20110113-C00256.png)
JP (1) JPS51100074A (US20110009641A1-20110113-C00256.png)
AT (1) AT357698B (US20110009641A1-20110113-C00256.png)
BE (1) BE837895A (US20110009641A1-20110113-C00256.png)
CA (1) CA1064913A (US20110009641A1-20110113-C00256.png)
CH (1) CH618960A5 (US20110009641A1-20110113-C00256.png)
DE (1) DE2602803A1 (US20110009641A1-20110113-C00256.png)
DK (1) DK29876A (US20110009641A1-20110113-C00256.png)
ES (1) ES444625A1 (US20110009641A1-20110113-C00256.png)
FR (1) FR2298336A1 (US20110009641A1-20110113-C00256.png)
GB (1) GB1537856A (US20110009641A1-20110113-C00256.png)
IE (1) IE42249B1 (US20110009641A1-20110113-C00256.png)
NL (1) NL7600764A (US20110009641A1-20110113-C00256.png)
SE (1) SE7600754L (US20110009641A1-20110113-C00256.png)
ZA (1) ZA76420B (US20110009641A1-20110113-C00256.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177133B (en) * 1977-07-18 1981-07-28 Richter Gedeon Vegyeszet Process for preparing angiotensin ii analogues containing alpha- amino-oxy-acid in position 1 with angiotensin ii antagonist activity
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
HU181009B (en) * 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for preparing angiotensin-ii analogues with antagonictic activity containing in position 1 sarcosyl,hydroxyacetyl or l-alpha-aminoxy-propionyl group and in positiona 8 esteric group
HU181008B (en) * 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886134A (en) * 1970-03-09 1975-05-27 Morton Norwich Products Inc Analogues of angiotensin II

Also Published As

Publication number Publication date
AT357698B (de) 1980-07-25
NL7600764A (nl) 1976-07-29
ATA48976A (de) 1979-12-15
US3975365A (en) 1976-08-17
GB1537856A (en) 1979-01-04
DE2602803A1 (de) 1976-07-29
ES444625A1 (es) 1977-05-16
ZA76420B (en) 1977-04-27
DK29876A (da) 1976-07-28
AU1056676A (en) 1977-08-04
IE42249L (en) 1976-07-27
CA1064913A (en) 1979-10-23
FR2298336A1 (fr) 1976-08-20
SE7600754L (sv) 1976-07-28
CH618960A5 (US20110009641A1-20110113-C00256.png) 1980-08-29
IE42249B1 (en) 1980-07-02
JPS51100074A (US20110009641A1-20110113-C00256.png) 1976-09-03
BE837895A (fr) 1976-07-26

Similar Documents

Publication Publication Date Title
FR2298336B1 (US20110009641A1-20110113-C00256.png)
AU496168B2 (US20110009641A1-20110113-C00256.png)
CH599589B5 (US20110009641A1-20110113-C00256.png)
CH599439A5 (US20110009641A1-20110113-C00256.png)
BE826796A (US20110009641A1-20110113-C00256.png)
BE846112A (US20110009641A1-20110113-C00256.png)
BG22301A1 (US20110009641A1-20110113-C00256.png)
BG22616A1 (US20110009641A1-20110113-C00256.png)
CH579442A5 (US20110009641A1-20110113-C00256.png)
CH581877A5 (US20110009641A1-20110113-C00256.png)
CH583647A5 (US20110009641A1-20110113-C00256.png)
CH586518A5 (US20110009641A1-20110113-C00256.png)
CH586541A5 (US20110009641A1-20110113-C00256.png)
CH587714A5 (US20110009641A1-20110113-C00256.png)
CH588663A5 (US20110009641A1-20110113-C00256.png)
CH589383A5 (US20110009641A1-20110113-C00256.png)
CH590391A5 (US20110009641A1-20110113-C00256.png)
CH592404A5 (US20110009641A1-20110113-C00256.png)
CH593320A5 (US20110009641A1-20110113-C00256.png)
CH593493A5 (US20110009641A1-20110113-C00256.png)
CH594132A5 (US20110009641A1-20110113-C00256.png)
CH595562A5 (US20110009641A1-20110113-C00256.png)
CH595989A5 (US20110009641A1-20110113-C00256.png)
CH596282A5 (US20110009641A1-20110113-C00256.png)
CH596385A5 (US20110009641A1-20110113-C00256.png)

Legal Events

Date Code Title Description
ST Notification of lapse